Serum Amyloid a Predicts Prognosis and Chemotherapy Efficacy in Patients with Advanced Pancreatic Cancer

PURPOSE: There is an urgent need to discover a predictive biomarker to help patients with advanced pancreatic cancer (APC) choose appropriate chemotherapy regimens. This study aimed to determine whether baseline serum amyloid A (SAA) levels were associated with overall survival (OS), progression-fre...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Honglu, Yang, Qiuxia, Mao, Yize, Qin, Dailei, Yao, Zehui, Wang, Ruiqi, Qin, Tao, Li, Shengping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045337/
https://www.ncbi.nlm.nih.gov/pubmed/36998322
http://dx.doi.org/10.2147/JIR.S404900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045337/
https://www.ncbi.nlm.nih.gov/pubmed/36998322
http://dx.doi.org/10.2147/JIR.S404900

Ejemplares similares